London calling logo

London Calling 2024 - Speakers

Speakers

Check out the line up of speaking at London Calling 2024.

Oxford Nanopore Technologies

Hannah Titheradge

Hannah Titheradge
Job title
Institution
Birmingham Women's and Children's NHS Foundation Trust, UK
Biography

Dr. Hannah Titheradge is a Consultant in Clinical Genetics at the Birmingham Women’s and Children’s NHS Foundation Trust and Honorary Clinical Associate Professor at the University of Birmingham. She is the Rare Disease lead for the Birmingham Women’s Hospital. Her research focus includes increasing the diagnostic rate for patients with rare monogenic disorders through reanalysis of existing genomic data and utilising other modalities such as long-read nanopore sequencing and RNA-Seq. She has published papers in Cell, eLife, and Human Mutation.Italic

Recent publications

Burleigh, A. et al. Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition. Front. Immunol. 14 (2023). DOI: https://doi.org/10.3389/fimmu.2023.1287258

Burleigh, A. et al. Genetic testing of Behçet's disease using next-generation sequencing to identify monogenic mimics and HLA-B*51. Rheumatology 628. (2023). DOI: https://doi.org/10.1093/rheumatology/kead628

McDermott, H. et al. Paediatric survivors beyond infancy with Stüve-Wiedemann syndrome — A case series from the West Midlands, UK. Eur. J. Med. Genet. 66(8) (2023). DOI: https://doi.org/10.1016/j.ejmg.2023.104788

Talks at this conference

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag